Enhancement of glucuronosyl etoposide transport by glutathione in multidrug resistance-associated protein-overexpressing cells

Cancer Letters

Volumn 135, Issue 1, 1998, Pages 113-119

  Sakamoto, Hiroshi ^a   Hara, Hirokazu ^a   Hirano, Kazuyuki ^a   Adachi, Tetsuo ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

ATP binding cassette transmembrane transporter; Buthionine sulfoximine; Cancer chemotherapy; Glucuronosyl etoposide; Glutathione; Multidrug resistance associated protein

Indexed keywords

ABC TRANSPORTER; BUTHIONINE SULFOXIMINE; ETOPOSIDE; GLUTATHIONE; LEUKOTRIENE C4; MULTIDRUG RESISTANCE PROTEIN;

ARTICLE; CELL STRAIN KB; CELL TRANSPORT; CONTROLLED STUDY; CYTOTOXICITY; DRUG TRANSPORT; DRUG UPTAKE; GENE EXPRESSION; HUMAN; HUMAN CELL; MEMBRANE VESICLE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; BUTHIONINE SULFOXIMINE; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; GLUCURONATES; GLUTATHIONE; HUMANS; KB CELLS; LEUKOTRIENE C4; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS;

EID: 0032446450     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00285-7     Document Type: Article

References (29)

1. [1] C. Chen, J.E. Chin, K. Udea, D.P. Clark, I. Pastan, M.M. Gottesman, I.B. Roninson, Internal duplication and homology with bacterial transport proteins in the mdrI (P-glycoprotein) gene from multidrug-resistant human cells, Cell 47 (1986) 381-389.
2. [2] H. Hamada, T. Tsuruo, Functional role for the 170-to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies, Proc. Natl. Acad. Sci. USA 83 (1986) 7785-7789.
3. [3] S.P.C. Cole, G. Bhardwaj, J.H. Gerlach, J.E. Mackie, C.E. Grant, K.C. Almquist, A.J. Stewart, E.U. Kurz, A.M.V. Doncan, R.G. Deeley, Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line, Science 258 (1992) 1650-1654.
4. [4] G. Jedlitschky, I. Leier, U. Buchholz, M. Center, D. Keppler, ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein, Cancer Res. 54 (1994) 4833-4836.
5. 4 and structurally related conjugates, J. Biol. Chem. 296 (1994) 27807-27810.
6. [6] G.J.R. Zaman, M.J. Flens, M.R. van Leusden, M. de Hass, H.S. Mülder, J. Lankelma, H.M. Pinedo, R.J. Scheper, F. Baas, H.J. Broxterman, P. Borst, The human multidrug resistance-associated protein MRP is plasma membrane drug-efflux pump, Proc. Natl. Acad. Sci. USA 91 (1994) 8822-8826.
7. [7] G.D. Kruh, A. Chan, K. Myers, K. Gaughan, T. Miki, S.A. Aaronson, Expression complementary DNA library transfer establishes mrp as a multidrug resistance gene, Cancer Res. 54 (1994) 1649-1652.
8. [8] H.X. Bing, V. Gupta, S.V. Singh, Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance, Arch. Biochem. Biophys. 308 (1994) 164-170.
9. [9] E. Schneider, H. Yamazaki, B.K. Sinha, K.H. Cowan, Buthionine sulphoximine-mediated sensitisation of etoposide-resistant human breast cancer MCF7 cells overexpressing the multidrug resistance-associated protein involves increased drug accumulation, Br. J. Cancer 71 (1995) 738-743.
10. [10] C.H.M. Versantvoort, H.J. Broxterman, T. Bagrij, R.J. Scheper, P.R. Twentyman, Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein, Br. J. Cancer 72 (1995) 82-89.
11. [11] G.J.R. Zaman, J. Lankelma, O. van Tellingen, J. Beijnen, H. Dekker, C. Paulusma, R.P.J. Oude Elferink, F. Baas, P. Borst, Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein, Proc. Natl. Acad. Sci. USA 92 (1995) 7690-7694.
12. [12] P.J. O'Dwyer, B. Leyland-Jones, M.T. Alonso, S. Marsoni, R.E. Wittes, Etoposide (VP-16-213): current status of an active anticancer drug, N. Engl. J. Med. 312 (1985) 692-700.
13. [13] Y. Hashimoto, T. Irie, Y. Nakai, M. Ochiai, N. Natume, Analysis of etoposide metabolites in rat bile. Identification of glucuronides, Chromatography 115 (1994) 153-159.
14. [14] M. D'Incalci, C. Rossi, M. Zucchetti, R. Urso, F. Cavalli, M. Costantino, Y. Willems, C. Sessa, Pharmacokinetics of etoposide in patients with abnormal renal and hepatic function, Cancer Res. 46 (1985) 2566-2571.
15. [15] K. Hande, L. Anthony, R. Hamilton, R. Benett, B. Sweetman, R. Branch, Identification of etoposide glucuronide as major metabolite of etoposide in the rat and rabbit, Cancer Res. 48 (1988) 1829-1834.
16. [16] K. Koike, T. Abe, T. Hisano, T. Kubo, M. Wada, K. Kohno, M. Kuwano, Overexpression of multidrug resistance protein gene in human cancer cell lines selected for drug resistance to epipodophyllotoxins, Jpn. J. Cancer Res. 87 (1996) 765-772.
17. [17] K. Koike, T. Kawabe, T. Tanaka, S. Toh, T. Uchiumi, M. Wada, S. Akiyama, M. Ono, M. Kuwano, A canalicular multi-specific organic anion transporter (cMORT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells, Cancer Res. 57 (1997) 5475-5479.
18. [18] G. Jedlitschky, I. Leier, U. Buchholz, K. Barnouin, G. Kurz, D. Keppler, Transport of glutathione, glucuronate and sulfate conjugates by the MRP gene-encoded conjugate export pump, Cancer Res. 56 (1996) 988-994.
19. [19] G. Jedlitschky, I. Leier, M. Böhme, U. Buchholz, J. Bar-Tena, D. Keppler, Hepatobiliary elimination of the peroxisome proliferator nafenopin by conjugation and subsequent ATP-dependent transport across the canalicular membrane, Biochem. Pharmacol. 48 (1994) 1113-1120.
20. [20] B. Page, M. Page, C. Noel, A new fluorometric assay for cytotoxicity measurements in vitro, Int. J. Oncol. 3 (1993) 473-476.
21. [21] S. Paul, L.M. Breuninger, G.D. Kruh, ATP-dependent transport of lipophilic cytotoxic drugs by membrane vesicles prepared from MRP-overexpressing HL60/ADR cells, Biochemistry 35 (1996) 14003-14011.
22. [22] E. Przybytkowski, D.A. Averill-Bates, Correlation between glutathione and stimulation of the pentose phosphate cycle in situ in Chinese hamster ovary cells exposed to hydrogen peroxide, Arch. Biochem. Biophys. 325 (1996) 91-98.
23. [23] M.M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72 (1976) 248-254.
24. 4 and chemotherapeutic agents in membrane vesicles, J. Biol. Chem. 271 (1996) 9675-9682.
25. [25] H. Takano, K. Kohno, M. Ono, Y. Uchida, M. Kuwano, Increased phosphorylation of DNA topoisomerase II in etoposide-resistant mutants of human cancer KB cells, Cancer Res. 51 (1991) 3951-3957.
26. [26] T. Kubo, K. Kohno, T. Ohga, K. Taniguchi, K. Kawanami, M. Wada, M. Kuwano, DNA topoisomerase IIα gene expression under transcriptional control in etoposide/teniposide-resistant human cancer cells, Cancer Res. 55 (1995) 3860-3864.
27. [27] M.T. Kuo, J.-J. Bao, S.A. Curley, M. Ikeguchi, D.A. Johnston, T. Ishikawa, Frequent coordinated overexpression of the MRP/GS-X pump and γ-glutamylcysteine synthetase genes in human colorectal cancers, Cancer Res. 56 (1996) 3642-3644.
28. [28] A. Gomi, T. Masuzawa, T. Ishikawa, M.T. Kuo, Posttranscriptional regulation of MRP/GS-X pump and γ-glutamylcysteine synthetase expression by 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea and by cycloheximide in human glioma cells, Biochem. Biophys. Res. Commun. 239 (1997) 51-56.
29. [29] T. Ishikawa, J.-J. Bao, Y. Yamane, K. Akimaru, K. Frindrich, C.D. Wright, M.T. Kuo, Coordinated induction of MRP/GS-X pump and γ-glutamylcysteine synthetase by heavy metals in human leukemia cells, J. Biol. Chem. 271 (1996) 14981-14988.